Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Wenwen Chien(National University Cancer Institute, Singapore), H. Phillip Koeffler(Cedars-Sinai Medical Center), Yueyuan Zheng(Guangzhou University of Chinese Medicine), Chehyun Nam(University of Southern California), Neil A. Bhowmick(Cedars-Sinai Medical Center), Sigal Gery(Cedars-Sinai Medical Center), Mohan Shankar Gopinatha Pillai(Cedars-Sinai Medical Center), Liyan Li(Kunming Medical University), Jeffrey Tyner(Washington University in St. Louis), De‐Chen Lin(University of Southern California)
Cited by 8
Related Papers
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.3k
IBS: an illustrator for the presentation and visualization of biological sequences
|Bioinformatics|2015|1.1k
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
|Journal of Clinical Investigation|1993|653
Molecular Cloning of Transferrin Receptor 2
|Journal of Biological Chemistry|1999|640
GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs
|Nucleic Acids Research|2014|541